Cerebral protection of epigallocatechin gallate (EGCG) via preservation of mitochondrial function and ERK inhibition in a rat resuscitation model

References

• Aronowski J, Strong R, Grotta JC. Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats. J Cereb Blood Flow Metab. 1997;17(10):1048–1056. doi:10.1097/00004647-199710000-000069346429
   PubMed Web of Science ®Google Scholar
• Schaller B, Graf R. Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy. J Cereb Blood Flow Metab. 2004;24(4):351–371. doi:10.1097/00004647-200404000-0000115087705
   PubMed Web of Science ®Google Scholar
• Del Castillo J, Lopez-Herce J, Canadas S, et al. Cardiac arrest and resuscitation in the pediatric intensive care unit: a prospective multicenter multinational study. Resuscitation. 2014;85(10):1380–1386. doi:10.1016/j.resuscitation.2014.06.02425008138
   PubMed Web of Science ®Google Scholar
• Bosson N, Kaji AH, Koenig W, et al. Re-examining outcomes after unsuccessful out-of-hospital resuscitation in the era of field termination of resuscitation guidelines and regionalized post-resuscitation care. Resuscitation. 2014;85(7):915–919. doi:10.1016/j.resuscitation.2014.04.00124735728
   PubMed Web of Science ®Google Scholar
• Kuschner CE, Becker LB. Recent advances in personalizing cardiac arrest resuscitation. F1000Research. 2019;8. doi:10.12688/f1000research.17554.1
   PubMedGoogle Scholar
• Merchant RM, Yang L, Becker LB, et al. Incidence of treated cardiac arrest in hospitalized patients in the United States. Crit Care Med. 2011;39(11):2401–2406. doi:10.1097/CCM.0b013e318225745921705896
   PubMed Web of Science ®Google Scholar
• Chen K, Schenone AL, Gheyath B, et al. Impact of hypothermia on cardiac performance during targeted temperature management after cardiac arrest. Resuscitation. 2019. doi:10.1016/j.resuscitation.2019.06.276
   Web of Science ®Google Scholar
• Zhang JC, Lu W, Xie XM, Pan H, Wu ZQ, Yang GT. Mild hypothermia attenuates post-resuscitation brain injury through a V-ATPase mechanism in a rat model of cardiac arrest. Genet Mol Res. 2016;15(2). doi:10.4238/gmr.15027729.
   Web of Science ®Google Scholar
• Feldenberg LR, Thevananther S, Del Rio M, de Leon M, Devarajan P. Partial ATP depletion induces Fas- and caspase-mediated apoptosis in MDCK cells. Am J Physiol. 1999;276(6):F837–F846.10362772
   PubMed Web of Science ®Google Scholar
• Adikesavan G, Vinayagam MM, Abdulrahman LA, Chinnasamy T. (-)-Epigallocatechin-gallate (EGCG) stabilize the mitochondrial enzymes and inhibits the apoptosis in cigarette smoke-induced myocardial dysfunction in rats. Mol Biol Rep. 2013;40(12):6533–6545. doi:10.1007/s11033-013-2673-524197690
   PubMed Web of Science ®Google Scholar
• Belobrov S, Seers C, Reynolds E, Cirillo N, McCullough M. Functional and molecular effects of a green tea constituent on oral cancer cells. J Oral Pathol Med. 2019. doi:10.1111/jop.12914
   PubMed Web of Science ®Google Scholar
• Huang SM, Chang YH, Chao YC, et al. EGCG-rich green tea extract stimulates sRAGE secretion to inhibit S100A12-RAGE axis through ADAM10-mediated ectodomain shedding of extracellular RAGE in type 2 diabetes. Mol Nutr Food Res. 2013;57(12):2264–2268. doi:10.1002/mnfr.20130027523901023
   PubMed Web of Science ®Google Scholar
• Schroeder EK, Kelsey NA, Doyle J, et al. Green tea epigallocatechin 3-gallate accumulates in mitochondria and displays a selective antiapoptotic effect against inducers of mitochondrial oxidative stress in neurons. Antioxid Redox Signal. 2009;11(3):469–480. doi:10.1089/ars.2008.221518754708
   PubMed Web of Science ®Google Scholar
• Zheng J, Ramirez VD. Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals. Br J Pharmacol. 2000;130(5):1115–1123. doi:10.1038/sj.bjp.070339710882397
   PubMed Web of Science ®Google Scholar
• Dragicevic N, Smith A, Lin X, et al. Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer’s amyloid-induced mitochondrial dysfunction. J Alzheimer’s Dis. 2011;26(3):507–521. doi:10.3233/JAD-2011-10162921694462
   PubMed Web of Science ®Google Scholar
• Krishnan TR, Velusamy P, Mangaiah S, et al. Epigallocatechin-3-gallate restores the Bcl-2 expression in liver of young rats challenged with hypercholesterolemia but not in aged rats: an insight into its disparity of efficacy on advancing age. Food Funct. 2014;5(5):916–926. doi:10.1039/c3fo60345h24584116
   PubMed Web of Science ®Google Scholar
• Nguyen Thi PA, Chen MH, Li N, Zhuo XJ, Xie L. PD98059 protects brain against cells death resulting from ROS/ERK activation in a cardiac arrest rat model. Oxid Med Cell Longev. 2016;2016:3723762. doi:10.1155/2016/372376227069530
   PubMed Web of Science ®Google Scholar
• Zheng JH, Xie L, Li N, et al. PD98059 protects the brain against mitochondrial-mediated apoptosis and autophagy in a cardiac arrest rat model. Life Sci. 2019;116618. doi:10.1016/j.lfs.2019.11661831265854
   PubMed Web of Science ®Google Scholar
• Zhu YM, Wang CC, Chen L, et al. Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats. Brain Res. 2013;1494:1–8. doi:10.1016/j.brainres.2012.11.04723219579
   PubMed Web of Science ®Google Scholar
• Wang PR, Wang JS, Zhang C, Song XF, Tian N, Kong LY. Huang-Lian-Jie-Du-Decotion induced protective autophagy against the injury of cerebral ischemia/reperfusion via MAPK-mTOR signaling pathway. J Ethnopharmacol. 2013;149(1):270–280. doi:10.1016/j.jep.2013.06.03523811213
   PubMed Web of Science ®Google Scholar
• Yang SI, Yuan Y, Jiao S, Luo QI, Yu J. Calcitonin gene-related peptide protects rats from cerebral ischemia/reperfusion injury via a mechanism of action in the MAPK pathway. Biomed Reports. 2016;4(6):699–703. doi:10.3892/br.2016.658
   PubMed Web of Science ®Google Scholar
• Chen MH, Liu TW, Xie L, et al. A simpler cardiac arrest model in rats. Am J Emerg Med. 2007;25(6):623–630. doi:10.1016/j.ajem.2006.11.03317606086
   PubMed Web of Science ®Google Scholar
• Jia X, Koenig MA, Shin HC, et al. Improving neurological outcomes post-cardiac arrest in a rat model: immediate hypothermia and quantitative EEG monitoring. Resuscitation. 2008;76(3):431–442. doi:10.1016/j.resuscitation.2007.08.01417936492
   PubMed Web of Science ®Google Scholar
• Lobo-Jarne T, Ugalde C. Respiratory chain supercomplexes: structures, function and biogenesis. Semin Cell Dev Biol. 2018;76:179–190. doi:10.1016/j.semcdb.2017.07.02128743641
   PubMed Web of Science ®Google Scholar
• Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med. 2010;48(6):749–762. doi:10.1016/j.freeradbiomed.2009.12.02220045723
   PubMed Web of Science ®Google Scholar
• Zhuo X, Xie L, Shi FR, Li N, Chen X, Chen M. The benefits of respective and combined use of green tea polyphenols and ERK inhibitor on the survival and neurologic outcomes in cardiac arrest rats induced by ventricular fibrillation. Am J Emerg Med. 2016;34(3):570–575. doi:10.1016/j.ajem.2015.12.01126783148
   PubMed Web of Science ®Google Scholar
• Park SY, Jeong YJ, Kim SH, Jung JY, Kim WJ. Epigallocatechin gallate protects against nitric oxide-induced apoptosis via scavenging ROS and modulating the Bcl-2 family in human dental pulp cells. J Toxicol Sci. 2013;38(3):371–378.23665936
   PubMed Web of Science ®Google Scholar
• Nakagawa H, Hasumi K, Woo JT, Nagai K, Wachi M. Generation of hydrogen peroxide primarily contributes to the induction of Fe(II)-dependent apoptosis in Jurkat cells by (-)-epigallocatechin gallate. Carcinogenesis. 2004;25(9):1567–1574. doi:10.1093/carcin/bgh16815090467
   PubMed Web of Science ®Google Scholar
• Nakagawa H, Wachi M, Woo JT, et al. Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-3-gallate to induce osteoclastic cell death. Biochem Biophys Res Commun. 2002;292(1):94–101. doi:10.1006/bbrc.2002.662211890677
   PubMed Web of Science ®Google Scholar
• Khiewkamrop P, Phunsomboon P, Richert L, Pekthong D, Srisawang P. Epistructured catechins, EGCG and EC facilitate apoptosis induction through targeting de novo lipogenesis pathway in HepG2 cells. Cancer Cell Int. 2018;18:46. doi:10.1186/s12935-018-0539-629588626
   PubMed Web of Science ®Google Scholar
• Wu DD, Liu ZG, Li JM, et al. Epigallocatechin-3-gallate inhibits the growth and increases the apoptosis of human thyroid carcinoma cells through suppression of EGFR/RAS/RAF/MEK/ERK signaling pathway. Cancer Cell Int. 2019;19. doi:10.1186/s12935-019-0762-9
   Web of Science ®Google Scholar
• Yamamoto N, Shibata M, Ishikuro R, et al. Epigallocatechin gallate induces extracellular degradation of amyloid beta-protein by increasing neprilysin secretion from astrocytes through activation of ERK and PI3K pathways. Neuroscience. 2017;362:70–78. doi:10.1016/j.neuroscience.2017.08.03028844000
   PubMed Web of Science ®Google Scholar
• Gee JR, Saltzstein DR, Kim K, et al. A Phase II randomized, double-blind, presurgical trial of polyphenon E in bladder cancer patients to evaluate pharmacodynamics and bladder tissue biomarkers. Cancer Prev Res. 2017;10(5):298–307. doi:10.1158/1940-6207.CAPR-16-0167
   PubMed Web of Science ®Google Scholar
• Wang XH, You YP. Epigallocatechin gallate extends therapeutic window of recombinant tissue plasminogen activator treatment for brain ischemic stroke: a randomized double-blind and placebo-controlled trial. Clin Neuropharmacol. 2017;40(1):24–28. doi:10.1097/WNF.000000000000019727941526
   PubMed Web of Science ®Google Scholar
• Shi DD, Guo JJ, Zhou L, Wang N. Epigallocatechin gallate enhances treatment efficacy of oral nifedipine against pregnancy-induced severe pre-eclampsia: a double-blind, randomized and placebo-controlled clinical study. J Clin Pharm Ther. 2018;43(1):21–25. doi:10.1111/jcpt.1259728726273
   PubMed Web of Science ®Google Scholar